Introduction
High-energy metabolites like lactate, pyruvate and ketone bodies are transported across cell membranes by monocarboxylate transporters (MCTs) in many tissues [1, 2] . The SLC16 gene family of MCTs comprises 14 isoforms, the first four of which (MCT1-4) transport monocarboxylates in cotransport with a proton in a 1 : 1 stoichiometry [1] . MCT4 is a low-affinity, highcapacity carrier with a K m value for lactate of 20-35 mM [3] . Due to the kinetics, MCT4 is well suited for the export of lactate from glycolytic cell types and also plays an important role in the control of intracellular pH by proton-coupled lactate release [4] . In skeletal muscle, e.g. MCT4 is highly expressed in white muscle fibres, which contain only few mitochondria [2] . During exercise, these glycolytic cells produce high amounts of lactate and protons, which are exported by MCT4. Lactate can either be released into the blood stream or be taken up and oxidised by red muscle fibres, which primarily express MCT1 [5, 6] . In the brain, MCT4 is expressed primarily in astrocytes, where it has been suggested (together with MCT1) to be responsible for the export of lactate to provide neurons with the high-energy metabolite during increased activity, a mechanism coined astrocyte to neuron lactate shuttle [7] [8] [9] [10] . Furthermore, MCT4 has been found to be highly upregulated in hypoxic Abbreviations CA, carbonic anhydrase; GST, glutathione S-transferase; MCT, monocarboxylate transporter. cells, such as many cancer cell types. These cells, often most aggressive and invasive tumours, rely on extensive glycolysis to meet their large demand for energy and biosynthetic precursors [11] [12] [13] [14] . The increase in glycolysis leads to the production of vast amounts of lactate and protons which have to be removed from cells to prevent massive intracellular acidosis and accumulation of lactate, which would result in inhibition of glycolysis and cytostasis [11] [12] [13] [14] .
Mammalian carbonic anhydrases (CA) of the a-class of CAs catalyse the reversible hydration of CO 2 to HCO À 3 and H + [15, 16] . Cytosolic CAII has been found to facilitate transport function of many acid/ base transporting membrane proteins, including the Cl À /HCO À 3 exchangers AE1 and AE2 [17] [18] [19] [20] , the Na + /HCO À 3 cotransporters NBCe1 and NBCn1 [21] [22] [23] [24] [25] [26] , and the Na + /H + exchanger NHE1 [27, 28] . This phenomenon, which requires both direct binding between transporter and enzyme, as well as CAII catalytic activity has been coined 'transport metabolon' (for detailed reviews on transport metabolons see [29] [30] [31] ). We have previously shown that transport activity of MCT1 and MCT4, respectively, is enhanced by CAII, when the two proteins are heterologously coexpressed in Xenopus oocytes [32] [33] [34] [35] [36] [37] [38] . In contrast to the 'transport metabolons' as described before, enhancement of MCT1/4 transport function is independent of the enzymes' catalytic activity, but requires direct binding of CAII to MCT. This binding is established by a cluster of three glutamic acid residues (E 489 EE in MCT1; E 431 EE in MCT4) in the transporter's C-terminal tail and a histidine residue (H 64 ) in CAII [36, 38] . In addition to the direct binding between the two proteins, CAII-mediated facilitation of MCT transport activity required the intramolecular proton shuttle of CAII [35] . From these data, we proposed that CAII functions as a 'proton antenna' for the transporter, which dissipates intracellular proton microdomains at the transporter pore and thereby maintain transport activity [35, 37] .
In the present study, we tested whether an endogenous proton antenna, generated by introduction of a cluster of histidine residues into the C-terminal tail of the transporter, could facilitate MCT4 transport activity. Our results show that integration of a cluster of six histidines does indeed increase transport activity of MCT4 to the same extent as did coexpression of MCT4-WT with CAII. These findings suggest that integration of the histidine cluster leads to formation of an endogenous proton antenna in MCT4, which facilitates H + /lactate flux across the cell membrane, similar as suggested for CAII.
Results

Introduction of histidine residues into the C terminus of MCT4 facilitates transport activity
We have shown previously that CAII, which directly binds to the C-terminal tail of MCT1 and MCT4, facilitates transport activity of these carriers, presumably by functioning as a 'proton antenna' for the transporter [32] [33] [34] [35] [36] [37] [38] . Therefore, CAII seems to facilitate its own intramolecular proton shuttle (a cluster of protonatable amino acids with the histidine at position 64 as the central residue) to move protons between the transporter pore and adjacent protonatable sites. To investigate whether a cluster of protonatable amino acids near the transporter pore per se is sufficient to function as 'proton antenna' to facilitate MCT transport function, we inserted a cluster of six histidine residues into the middle part of the cytoplasmic C-terminal tail of MCT4 (MCT4-6xHis; Fig. 1D ). Transport activity of MCT4-6xHis was then compared to the activity of MCT4-WT and MCT4-WT coexpressed with CAII by determining the rate of change in intracellular H + concentration (Δ[H   + ] i /Δt) during application and removal of 3 and 10 mM lactate in Xenopus oocytes (Fig. 1A) . Indeed, introduction of six histidine residues facilitated transport activity of MCT4 by nearly a factor of 2, and to the same extent as did coexpression of MCT4-WT with CAII (Fig. 1B,  C) . Integration of the histidines did not change the expression level of MCT4-6xHis as compared to MCT4-WT by western blot analysis ( Fig. 2A) . Furthermore, both MCT4-WT and MCT4-6xHis were integrated into the oocyte plasma membrane as shown by antibody staining against MCT4 (Fig. 2B) .
Injection of an antibody against the histidine cluster impairs transport activity of MCT4-6xHis
To investigate whether direct blocking of the histidine cluster could impair the antenna function in MCT4-6xHis, we injected an anti-His-Tag antibody (Anti-His) into oocytes expressing either MCT4-WT or MCT4-6xHis. Interestingly, injection of 15 ng of Anti-His, 1 day before the experiment, decreased transport activity of MCT4-6xHis to a value well below the transport activity of MCT4-WT, as indicated by a significant decrease in Δ[H + ] i /Δt during addition and removal of lactate ( Fig. 3A-C) . In contrast to MCT4-6xHis, transport activity of MCT4-WT was not influenced by injection of Anti-His (Fig. 3A-C) . To check whether injection of Anti-His into the oocyte alters the cells intrinsic buffer capacity (b i ), which in turn would result in an alteration of the measured Δ[H + ] i /Δt, we determined b i by measuring the change in intracellular pH during application of the weak acid CO 2 . Injection of Anti-His, however, did not lead to any significant change in intracellular buffer capacity (Fig. 3D) , which varied between 12 and 15 mM [39] . This supports the conclusion that Anti-His decreases lactate-induced proton flux (J H ) in MCT4-6xHis below the rate of flux observed for MCT4-WT (Fig. 3E) . Specificity of AntiHis was determined by immunohistochemistry. Therefore, Anti-His was again injected into oocytes expressing MCT4-WT and MCT4-6xHis, respectively, and into native oocytes as control. One day after injection, cells were fixed and 100 lm thick sections were created which were then additionally stained with a polyclonal antibody directed against an epitope in the C-terminal tail of MCT4-WT and MCT4-6xHis (Anti-MCT4). In oocytes expressing MCT4-6xHis, both antibodies produced a robust signal at the cell membrane with only slight background staining in the cytosol (Fig. 4A 1-3 ). However, in oocytes expressing MCT4-WT, only Anti-MCT4 produced a signal at the membrane, while no signal could be observed for Anti-His (Fig. 4B 1-3 ), indicating specific binding of the Anti-His antibody to MCT4-6xHis when injected in oocytes. Staining of native oocytes produced only slight background staining with both antibodies (Fig. 4C 1-3 ) . Injection of Anti-His did not change the expression level of MCT4 as confirmed by quantitative western blot analysis (Fig. 4D 1,2 ) . From these data, we conclude that the decrease in MCT4-6xHis transport capacity results from a direct effect of Anti-His on the transporter.
Transport activity of MCT4-6xHis can be further enhanced by extracellular CAIV but not by intracellular CAII
To check whether transport activity of MCT4-6xHis can be further enhanced by intracellular and extracellular CAs, we coexpressed MCT4-6xHis or MCT4-WT with CAII (intracellular), CAIV (extracellular) or with both isoforms together. While transport activity of MCT4-WT was significantly enhanced by coexpression with CAII, no influence of CAII on transport activity of MCT4-6xHis could be observed (Fig. 5A-D) . In contrast to CAII, coexpression of CAIV significantly enhanced transport activity of both MCT4-WT and MCT4-6xHis (compare Figs 5B and 6B). While transport activity of oocytes coexpressing MCT4-WT+CAIV was further enhanced by coexpression with CAII, no further effect of CAII could be observed in oocytes coexpressing MCT4-6xHis and CAIV ( Fig. 6A-D) . Neither expression of MCT4-WT nor MCT4-6xHis was altered by coexpression with CAII or CAIV, as determined by western blot analysis (Figs 5E and 6E). Thus, it seems that transport activity of MCT4-6xHis, with the His cluster at the intracellular C terminus, can be further enhanced by extracellular CAIV, but not by intracellular CAII.
Introduction of the histidine cluster suppresses binding of CAII to MCT4-6xHis
We have recently shown that facilitation of MCT4 transport activity by CAII requires direct binding of the enzyme to an acidic cluster within the C-terminal tail of the transporter (Fig. 1D , blue circles; [36] ). To investigate whether the inability of CAII to enhance transport activity results from the inability of the enzyme to bind to the modified C-terminal tail of the transporter, we performed a pull-down assay with a glutathione S-transferase (GST) fusion protein of the C-terminal tail of MCT4-WT or MCT4-6xHis and CAII (Fig. 7A) . GST alone was used as negative control. While CAII bound to the C-terminal tail of MCT4-WT, no binding between CAII and the C-terminal tail of MCT4-6xHis could be observed (Fig. 7B) .
Therefore, it appears likely that the histidine cluster, introduced into the C-terminal tail of MCT4-6xHis, impairs binding of CAII and disables the enzyme to further enhance transport activity.
Discussion
The present study shows that introduction of six histidine residues into the C-terminal tail of MCT4 leads to a significant increase in transport activity. We have shown previously that cytosolic CAII, which binds to the C-terminal tail of MCT4 [36] , also facilitates MCT4 transport function [34] [35] [36] . The CAII-mediated increase in MCT4 transport activity was independent of the enzyme's catalytic activity, but required the CAII intramolecular proton shuttle [34, 35] . These findings led to the conclusion that CAII functions as a 'proton antenna' for the transporter, which dissipates local H + microdomains around the transporter pore. The requirement for such a proton antenna has been proposed for H + cotransporters such as MCTs [40, 41] and H + -translocating enzymes like cytochrome oxidase and bacteriorhodopsin [42] . As their substrate is present at very low concentrations, these transporters and enzymes utilise protons at a much higher rate than protons could be provided to the proteins by simple diffusion through the cytosol [40, 41] . Yet, buffer molecules can remove H + from a protonated site within less than a ls, which is much shorter than the turnover time of most transporters and enzymes [42] . Therefore, these proteins require a mechanism that quickly binds protons and retains them from mobile buffer molecules. Proton-utilising enzymes like cytochrome oxidase (CcO) and bacteriorhodopsin (BR) do therefore possess an aggregate of protonable residues that assist each other in the binding of bulk protons either by the joining of their Coulomb cages or by rapid exchange of protons among themselves. This proton-collecting antenna captures protons and funnel them into an orifice from which a 'proton-wire' introduces them into the protein [42] [43] [44] [45] [46] [47] [48] [49] [50] .
MCT4 does not seem to possess an endogenous proton antenna, but seems to utilise the intramolecular proton pathway of CAII for this purpose. CAII uses a network of acidic amino acid residues, a histidine residue at position 64, and a wire of highly ordered water molecules that extends from the surface of the enzyme into its active site, to rapidly exchange protons between the catalytic centre and the surrounding protonatable residues [51, 52] . If MCT4 uses the protoncollecting antenna of CAII, bound to the transporter's C-terminal tail, to reach full transport activity, then introduction of an endogenous proton antenna into the C-terminal tail of MCT4 should also increase activity of MCT4. To test this hypothesis, we integrated a cluster of six histidine residues into the C-terminal tail of MCT4. It has been observed that in several H + -transporting enzymes which possess endogenous 'proton-collecting antennae', such as CcO and BR, the antennae are constituted by several histidine residues, which in turn are surrounded by negatively charged aspartate and glutamate residues [42] [43] [44] [45] [46] [47] [48] [49] [50] . Considering these structural features of the proton antenna, the histidine cluster was added into the middle of the C-terminal tail, where the cluster is flanked by several aspartate and glutamate residues. Together with these acidic amino acids within the transporter's C-terminal tail, which could function as 'proton collector', the histidine cluster, which acts as 'proton retainer', should form a proton antenna for the transporter. In that case, the histidine residues would function as local 'proton reservoir' (one could also say 'local buffer'), which allows the rapid supply of protons to the entry point of the H + transfer pathway. During efflux of protons and lactate endogenously present, negatively charged aspartate and glutamate residues could then function as 'proton collectors' which could rapidly collect H + from the bulk solution and subsequently donate them to histidine moiety. Thereby the 'proton collectors' would facilitate the rapid reprotonation of the histidine moiety by the bulk solution.
Rat MCT4, as used in this study, has 17 glutamate and aspartate residues distributed along its C-terminal tail and around the intracellular part of the transporter pore. However, which ones of these 17 residues might function as 'proton collectors' for MCT4-6xHis has not been investigated in this study. During efflux of lactate and protons, the negatively charged aspartate and glutamate residues close to the vicinity of transporter pore would collect H + from the exit point of the pore and shuttle them to the histidine cluster. The pK a of free histidine is 6.0 [53] , while in proteins, the pK a can range from 5.0 to 8.0 [54] , making histidines optimal candidates for rapid protonation and deprotonation sites. After delivering H + to nearby protonable groups at the plasma membrane, the histidine residues are rapidly reprotonated via surrounding aspartate and glutamate residues that collect H + from the transporter pore. In this context, the inserted histidine residues would maintain the connectivity of the H + -binding sites and thereby form an antenna surface around the transporter pore. And indeed, introduction of the histidine cluster into the C-terminal tail of MCT4 increased transport activity both in direction of influx and efflux and to the same extent as did CAII. Therefore, it could be speculated that several protonatable residues at the surface of CAII could function as a proton antenna that facilitates transport activity of MCT4-WT in the same manner as does the proton antenna, integrated into the C-terminal tail of MCT4-6xHis. However, further experiments on CAII have to be made to finally answer this question.
Interestingly, transport activity of this MCT4-6xHis mutant could be further enhanced by coexpression with extracellular CAIV. In a recent study, we could show that intracellular CAII and extracellular CAIV could enhance transport activity of MCT1 and MCT4 and that the effect of both CA isoforms are additive for MCT transport function [55] . In that study, we concluded that a proton antenna on only one side of the membrane might lead to an increased formation of a proton microdomain on the other side of the membrane. When supply (or removal) of H + is enhanced on the cis-side, the increase in MCT transport activity would then lead to an increased accumulation (or depletion) of H + at the trans-side, which would then again hinder MCT transport activity. With a proton antenna on both sides of the membrane, formation of H + microdomains would be suppressed on both cis-and trans-side. Therefore, it appears plausible that the endogenous proton antenna in MCT4-6xHis exacerbates the proton microdomain at the extracellular site of the transporter. In that case, CAIV would reduce the extracellular proton microdomain to further drive transport activity of MCT4-6xHis.
In contrast to CAIV, CAII was not able to further enhance transport activity of MCT4-6xHis, and the pull-down assay showed no binding between CAII and MCT4-6xHis. As facilitation of MCT4 transport activity requires direct binding of CAII to E 431 EE in the Cterminal tail of MCT4 [36] , the failure of CAII to enhance transport activity of MCT4-6xHis could be attributed to the inability of the enzyme to bind to the transporter. Why addition of the six histidine residues hinders binding of CAII to the glutamic acid cluster, which is located 14 amino acids upstream of the histidine cluster, remains yet unclear. However, as binding of CAII to E 431 EE in MCT4 is mediated by the histidine at position 64 in CAII, it could be speculated that the introduced histidine cluster directly interacts with E 431 EE in the C-terminal tail of MCT4-6xHis and thereby impairs binding of CAII.
Injection of an antibody against the histidine cluster decreased transport activity of MCT4-6xHis. However, as transport activity of MCT4-6xHis was decreased even below the transport activity of MCT4-WT, the decrease could not only be explained by inhibition of the proton antenna by the antibody, as this should decrease transport activity of MCT4-6xHis only to the transport activity of MCT4-WT, but not below. In contrast to MCT4-6xHis, injection of the Anti-His antibody had no effect on transport activity of MCT4-WT. Furthermore, a signal for Anti-His could only be observed in oocytes expressing MCT4-6xHis, but not in oocytes expressing MCT4-WT by fluorescent microscopy. Therefore, it appears unlikely that the antibody binds to another epitope than the histidine cluster in MCT4. Furthermore, we could show previously that truncation of the distal part of the MCT4 C-terminal tail (MCT4-S430X) does not impair transport activity [36] . It appears most likely that binding of the antibody to the histidine cluster in the C-terminal tail of MCT4-6xHis sterically hinders transport activity.
The data presented in this study are consistent with the formation of a proton antenna in MCT4-6xHis. However, there might be alternative theories to explain the enhancement in transport activity of MCT4-6xHis. As the charge of histidine residues is pH-dependent, it is possible that changes in intracellular pH modulate the electrostatic interaction between the C-terminal tail of MCT4-6xHis and charged residues at the inner surface of the plasma membrane. This altered interaction might facilitate MCT4 transport activity by altering the flexibility of the transporter. Furthermore, it appears possible that insertion of the histidine cluster may induce a conformational change in the transporter, which renders the binding site more accessible to the substrate, thereby enhancing transport activity. However, further experimental studies are required to verify these alternative mechanisms.
In the end it can be concluded that introduction of a cluster of histidines into the C-terminal tail of MCT4 can, together with other acidic amino acids in the C-terminal tail, form a proton antenna that can drive MCT transport activity by the same mechanism that facilitates the CAII-mediated increase in MCT4 transport function. One might ask, why MCT4 does not possess an endogenous proton antenna in its Cterminal tail per se, but requires CAII to move protons between transporter pore and adjacent protonatable sites. The omnipresence of CAII in MCT4-expressing cells may simply make the requirement for an endogenous antenna unnecessary. Alternatively, the CAIImediated increase in MCT4 transport activity, which requires direct binding of the enzyme to the transporter, may provide a possibility for the cell to regulate H + /lactate cotransport across the plasma membrane by the regulation of the binding between MCT4 and CAII. Further experiments are required to answer this question.
Experimental procedures
Introduction of six histidine residues into MCT4 by oligonucleotide cloning Rat MCT4, cloned in the oocyte expression vector pGEMHe-Juel (MCT4-WT; [3] ) was used as back-bone vector for cloning. For introduction of six histidine residues into the C terminus of MCT4, synthetic 37-mer complementary oligonucleotides containing codons for six histidine residues, flanked by a XhoI restriction site (Table 1) were hybridised at room temperature in the presence of CutSmart restriction buffer (New England Biolabs GmbH, Frankfurt am Main, Germany). Hybridised oligonucleotides and MCT4-WT vectors were digested with XhoI (CutSmart XhoI; New England Biolabs). The digested MCT4-WT vectors were dephosphorylated by the treatment of alkaline phosphatase (FastAP thermo sensitive alkaline phosphatase; Thermo Fisher, Schwerte, Germany) and cleaned up, using the GeneJet Plasmid Miniprep Kit (Thermo Fisher). The ligation of the digested hybridised oligonucleotide and the MCT4-WT vector (in the ratio of 3 : 1) was carried out following the manufacturer's instructions, using a rapid DNA ligation kit (Thermo Fisher) and the ligated mixture was transformed into Escherichia coli DH5a cells (Invitrogen, Thermo Fisher). The identity of the final vector, MCT4-6xHis, was confirmed by sequencing.
Heterologous protein expression in Xenopus oocytes
Plasmid DNA of rat MCT4-WT, rat MCT4-6xHis, human CAII-WT, and human CAIV-WT, respectively, cloned into the oocyte expression vector pGEM-He-Juel, which contains the 5 0 and the 3 0 untranscribed regions of the Xenopus b-globin flanking the multiple cloning site was linearised with SalI (Fermentas FastDigest SalI; Thermo Fisher) and transcribed in vitro with T7 RNA-Polymerase (Ambion mMessage mMachine, Life Technologies) as described earlier [33] . Xenopus laevis females were purchased from Xenopus Express, Vernassal, France. Segments of ovarian lobules were surgically removed under sterile conditions from frogs anaesthetised with 3 gÁL À1 of 3-amino-benzoic acid ethylester (MS-222; Sigma-Aldrich, Munich, Germany), and rendered hypothermic. The procedure was approved by the Landesuntersuchungsamt Rheinland-Pfalz, Koblenz (23 177-07/A07-2-003 §6). Oocytes were singularised by collagenase (Collagenase A; Roche, Mannheim, Germany) treatment and stored overnight in oocyte saline (in mM: 82.5 NaCl, 2.5 KCl, 1 CaCl 2 , 1 MgCl 2 , 1 Na 2 HPO 4 , 5 HEPES), supplemented with gentamycin, at 18°C to recover. For protein expression, oocytes were injected with cRNA coding for MCT4-WT (5 ng cRNA), MCT4-6xHis (5 ng), CAII-WT (12 ng), CAIV (2 ng), respectively, using a microinjection system (WPI Nanoliter 2000; World Precision Instruments Germany GmbH, Berlin, Germany). Measurements were carried out 3-6 days after injection of cRNA.
Measurement of intracellular H + concentration in Xenopus oocytes
All measurements were carried out in HEPES-buffered solution (in mM: 82.5 NaCl, 2.5 KCl, 1 CaCl 2 , 1 MgCl 2 , 1 Na 2 HPO 4 , 5 HEPES). In lactate-containing saline, NaCl was replaced by an equivalent amount of Na-L-lactate. Application of lactate was always carried out in HEPESbuffered solution at pH 7.0, in the nominal absence of CO 2 /HCO À 3 , containing around 0.008 mM of CO 2 from air and hence a HCO À 3 concentration of less than 0.2 mM. To check for catalytic activity of CA, a short CO 2 pulse was applied after the final lactate pulse. For this solution, NaCl was replaced by 10 mM NaHCO 3 and the solution was aerated with 5% CO 2 /95% O 2 .
For measurement of intracellular H + concentration and membrane potential, single-barrelled microelectrodes were used; the manufacture and application have been described in detail previously [56, 57] . Briefly, a borosilicate glass capillary of 1.5 mm in diameter was pulled to a micropipette and was silanised with a drop of 5% tri-N-butylchlorsilane in 99.9% pure carbon tetrachloride, backfilled into the tip. The micropipette was baked for 4.5 min at 450°C on a hot plate. H + -sensitive cocktail (Hydrogen ionophore I -cocktail A, Sigma-Aldrich) was backfilled into the silanised tip and filled up with 0.1 M Na-citrate, pH 6.0. The reference electrode was filled with 3 M KCl. Calibration of the electrodes was carried out in oocyte salines with a pH of 7.0 and 6.4. As described previously [58] , optimal pH changes were detected when the electrode was located near the inner surface of the plasma membrane. During all measurements, oocytes were clamped to a holding potential of À40 mV using an additional microelectrode, filled with 3 M KCl and connected to an Axoclamp 2A amplifier (Axon Instruments, Union City, CA, USA). All experiments were carried out at room temperature (22-25°C). The measurements were stored digitally using custom made PC 
Immunohistochemical analysis of MCT4-WT and MCT4-6xHis
Xenopus oocytes, expressing MCT4-WT and MCT4-6xHis, respectively, as well as native control oocytes were fixed in 4% paraformaldehyde in phosphate-buffered saline (PBS; Roti-Histofix 4%; Roth, Karlsruhe, Germany) 4 days after cRNA injection. After fixation, 100 lm sections were produced from oocytes embedded in 2% low melting agarose using a microtome (752M Vibroslice; Campden Instruments Ltd., Loughborough, UK). Unspecific binding sites were
The sequence of the sense oligonucleotide contains nucleotides encoding the histidine residues (denoted as bold) and XhoI restriction site (denoted by underline). Additional nucleotides (denoted as italic) are added at the both end of the oligo to facilitate the XhoI binding. One additional nucleotide (denoted as lower case) between XhoI restriction site and histidines encoding sequence is added to maintain the coding sequence in frame. Sequences of the antisense oligonucleotide are reversed complementary of the sense oligonucleotide. 
Western blot analysis
For comparison of protein levels of expressed MCT4, western blot analyses were performed. For each sample, 20 oocytes were lysed by pipetting in 2% sodium dodecylsulfate solution with protease inhibitor (Complete Mini EDTA-free; Roche) 4 days after injection of cRNA. Total protein content was determined using a Direct Detect Ò Infrared Spectrometer (Merck Millipore, Darmstadt, Germany). Extracts were separated by 4-12% SDS/polyacrylamide gel electrophoresis (SDS/PAGE) and transferred to nitrocellulose membranes. Proteins of interest were detected by antibody staining, using rabbit anti-rat MCT4 polyclonal antibody (AB3314P; Millipore) at a dilution of 1 : 400. As a loading control, b-tubulin was labelled with anti-b-tubulin mouse monoclonal antibody (1 : 500, Clone TUB 2.1 T5201; Sigma-Aldrich). Primary antibodies against MCT4 and btubulin were labelled with goat anti-rabbit IgG and goat anti-mouse IgG horseradish peroxidase-conjugated secondary antibody respectively (diluted 1 : 10 000; Santa Cruz Biotechnology Inc., Heidelberg, Germany). Membranes were analysed after incubation with luminata classico western HRP substrate (Millipore) with an Odyssey Fc dual-mode imaging system (Li-Cor Biosciences, Bad Homburg, Germany). Quantification of MCT4 protein was carried out with the software IMAGEJ (National Institutes of Health, Bethesda, MD, USA). Each individual signal for MCT4 was normalised to the signal of the b-tubulin signal from the same probe. To allow comparison of different western blots, all measured protein concentrations on one blot were normalised to the concentration of one protein on the same blot.
Pull-down of CAII with GST fusion proteins C terminus of MCT4-WT and MCT4-6xHis were cloned into the expression vector pGEX-2T (GE Healthcare Europe GmbH, Freiburg im Breisgau, Germany) and transformed into E. coli BL21 cells. Protein expression was induced by addition of 0.8 mM isopropyl-b-D-thiogalactopyranosid (IPTG). About 3 h after induction, cells were harvested and resuspended in phosphate-buffered saline (PBS) and lysed with lysis buffer (PBS, 2 mM MgCl 2 , 1% Triton X-100) in the presence of protease inhibitors (protease inhibitor cocktail tablets; Roche). Bacterial lysates were centrifuged for 15 min at 4°C, 12 000 g and the supernatant, containing the GST fusion protein (bait protein), was collected for further use. CAII-WT was expressed in Xenopus oocytes. For each experiment, 25 oocytes were lysed in lysis buffer in the presence of protease inhibitors (Roche). Oocyte lysates were centrifuged for 15 min at 4°C, 12 000 g and the supernatant (prey protein) was collected for further use. The pull-down experiment was carried out using the Pierce GST protein interaction pull-down kit (Thermo Fisher). Briefly, for immobilisation of GST fusion protein, 400 lg of bacterial lysate was added to a column containing 50 lL of 50% slurry of glutathione agarose and incubated for 2 h at 4°C with end-over-end mixing. After incubation, the excess bait protein was removed by centrifugation (4°C, 700 g) and the beads were washed five times with wash buffer (1 PBS : 1 lysis buffer). About 400 lL of oocyte lysate, containing CAII-WT, was added to the column and incubated for 2 h at 4°C with endover-end mixing. After incubation, the excess prey protein was removed by centrifugation (4°C, 700 g) and the beads were washed five times with wash buffer. Protein was eluted from the beads with 250 lL of elution buffer (10 mM glutathione in PBS, pH 8.0).
To determine the relative amount of GST and CAII, an equal volume of the samples was analysed by western blotting. GST was detected using a primary anti-GST antibody (dilution 1 : 400, anti-GST tag mouse monoclonal IgG, no. 05-782; Millipore) and a goat anti-mouse IgG horseradish peroxidase-conjugated secondary antibody (dilution 1 : 12 000; Santa Cruz). CAII was detected using a primary anti-CAII antibody (human erythrocytes) (dilution 1 : 400, rabbit anti-CAII polyclonal antibody, AB1828; Millipore) and a goat anti-rabbit IgG horseradish peroxidase-conjugated secondary antibody (dilution 1 : 12 000; Santa Cruz). Membranes were analysed after incubation with luminata classic western HRP substrate (Millipore) with an Odyssey Fc dual-mode imaging system (Li-Cor Biosciences). Quantification of the band intensity was carried out with the software IMAGEJ. To overcome variations in the signal intensity between different blots, signal intensity of each band for CAII was normalised to the signal intensity of the band from the pull-down of CAII with the GST fusion protein of the fulllength C terminus. To account for variations in the amount of GST fusion protein, each normalised signal for CAII was divided by the corresponding, normalised signal for GST.
Calculation and statistics
Statistical values are presented as means AE standard error of the mean. For calculation of significance in differences, Student 0 s t-test or, if possible, a paired t-test was used. In the figures shown, a significance level of P ≤ 0.05 is marked with *, P ≤ 0.01 with ** and P ≤ 0.001 with ***. 
